Amplitude Surgical SA represents a dedication to excellence, innovation, and patient care in the field of medical technology. The company values quality and precision in designing and manufacturing orthopedic surgical instruments and implants. With a focus on improving surgical outcomes and promoting patient well-being, Amplitude Surgical SA strives to provide cutting-edge solutions for orthopedic surgeons worldwide. The corporate philosophy is centered around collaboration, research, and continuous improvement to ensure the highest standards are met. Amplitude Surgical SA's commitment to advancement in orthopedics is evident in their strong portfolio and commitment to delivering reliable, efficient, and effective products.

Amplitude Surgical SA is primarily present in several countries and regions worldwide. These include France, its home country, as well as other key markets such as Germany, Spain, Italy, Belgium, the Netherlands, the United Kingdom, Switzerland, and Austria. With a strong global presence, Amplitude Surgical SA caters to the needs of patients, surgeons, and healthcare professionals across these regions.

Amplitude Surgical SA has achieved significant milestones in its history. Some notable achievements include the company's successful IPO in 2017, which consolidated its position as a key player in the orthopedic surgical market. Additionally, Amplitude Surgical SA has expanded its global presence by establishing subsidiaries and distribution networks in various countries. The company has also received several regulatory approvals for its innovative medical devices, enhancing its product portfolio. These milestones highlight Amplitude Surgical SA's commitment to delivering high-quality surgical solutions and its continuous efforts to improve patient outcomes.

Amplitude Surgical SA, a leading medical device company, specializes in designing and manufacturing innovative orthopedic implants and surgical instruments for orthopedic surgeons. Established in 1997, Amplitude Surgical has grown into a global player in the field of orthopedics. The company is headquartered in Valence, France, and operates in more than 30 countries worldwide. Amplitude Surgical SA prides itself on delivering high-quality and innovative solutions for joint replacement surgeries, including prosthetic hips and knees, aiming to improve patients' quality of life. With a strong emphasis on research and development, Amplitude Surgical SA continues to expand its product portfolio and reputation across the globe.

The main competitors of Amplitude Surgical SA in the market are companies such as Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc, Medtronic plc, and Smith & Nephew plc.

Amplitude Surgical SA is primarily active in the medical device industry, specializing in orthopedic surgery. They focus on developing and manufacturing innovative surgical solutions for the treatment of bone and joint disorders. With a strong expertise in orthopedic implants and instruments, Amplitude Surgical SA caters to various medical specialties, including traumatology, spine surgery, and arthroplasty. Their products are designed to enhance surgical precision and efficiency, providing healthcare professionals with reliable tools to improve patient outcomes in the field of orthopedic surgery.

The business model of Amplitude Surgical SA revolves around providing innovative and high-quality orthopedic medical devices for orthopedic surgeons worldwide. The company specializes in the design, manufacture, and distribution of surgical implants, instruments, and surgical navigation systems for joint replacement surgeries. Amplitude Surgical SA aims to improve patient outcomes and surgeon experience by offering a comprehensive range of products that ensure optimal surgical precision and efficiency. With a focus on research and development, Amplitude Surgical SA continuously adapts its product portfolio to meet the evolving needs of the orthopedic industry.

De Amplitude Surgical K/W is -3,14.

De Amplitude Surgical KUV is 1,36.

De AlleAktien Kwaliteitsscore voor Amplitude Surgical is 4/10.

De verwachte Amplitude Surgical omzet is 111,05 mln. EUR.

De verwachte Amplitude Surgical winst is -47,97 mln. EUR.

Amplitude Surgical SA is a leading provider of innovative medical devices for orthopedic surgery. The company offers a wide range of products for orthopedic surgeons to treat conditions such as arthritis, vascular injuries, osteoporosis, and more. Amplitude Surgical SA focuses on providing high-quality, safe, and effective products through collaboration with global experts in orthopedic surgery and conducting clinical studies. The company operates in two main areas: Total Knee Arthroplasty (TKA) and Total Hip Arthroplasty (THA). In addition to its main areas of focus, Amplitude Surgical SA also offers products for spine and shoulder surgery. The company has its headquarters in France and a global network of distribution and marketing partners. With its commitment to quality, safety, and effectiveness, as well as its wide range of products and global presence, Amplitude Surgical SA is poised for further growth.

Amplitude Surgical keert een dividend van 0 EUR uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Amplitude Surgical of het bedrijf keert geen dividend uit.

De ISIN van Amplitude Surgical is FR0012789667.

Het WKN van Amplitude Surgical is A14UZ2.

De ticker van Amplitude Surgical is AMPLI.PA.

Binnen de laatste 12 maanden betaalde Amplitude Surgical een dividend van . Dit komt overeen met een dividendrendement van ongeveer . Voor de komende 12 maanden zal Amplitude Surgical naar verwachting een dividend van 0 EUR betalen.

De dividendrendement van Amplitude Surgical is momenteel .

Amplitude Surgical betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden .

Amplitude Surgical betaalde de afgelopen 0 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0 EUR verwacht. Dit komt overeen met een dividendrendement van 0 %.

Amplitude Surgical wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van Amplitude Surgical van 18-11-2024 ter hoogte van 0 EUR te ontvangen, moest je het aandeel voor de ex-datum op 18-11-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 18-11-2024.

In het jaar 2023 heeft Amplitude Surgical 0 EUR aan dividenden uitgekeerd.

De dividenden van Amplitude Surgical worden in EUR uitgekeerd.